-- 惠譽評級在近期發布的報告中指出,健康的跨國財富和資本流動緩解了香港銀行業近期的獲利壓力。 惠譽表示,由於資金流入增加,香港銀行業去年的財富管理費收入實現了兩位數成長,存款流入也保持穩健。 惠譽指出,儘管由於基數較高以及地緣政治風險(尤其是伊朗衝突)的影響,這一趨勢將在2026年持續,但成長可能會放緩。 惠譽表示,政策舉措和不斷增長的IPO活動幫助香港保持了其作為區域財富中心的地位,從而帶動了非居民銀行帳戶、經紀業務量和投資產品分銷的穩健增長。 惠譽表示,由此帶來的手續費和收入增長以及低成本存款的激增,抵消了貸款需求疲軟、淨息差下降以及因本地商業地產敞口而導致的信貸成本上升等盈利壓力。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.